Story perspectives

Revolutionary Sequencing Tech Enhances Hereditary Cancer Detection

3/19/2026

Summary

Story summary

Long-read sequencing (LRS) technologies from Pacific Biosciences and Oxford Nanopore Technologies advance hereditary cancer research by improving detection of structural variants and epigenetic modifications.
Their longer reads map repetitive genomic regions more accurately than short-read sequencing.
Studies show LRS identifies more unique structural variants and resolves intronic insertions and abnormal RNA splicing.
Fiber-Seq enables profiling of chromatin accessibility and epigenetic marks, informing genetic predispositions to disease.

1 of 1

Story summary

Long-read sequencing (LRS) technologies from Pacific Biosciences and Oxford Nanopore Technologies advance hereditary cancer research by improving detection of structural variants and epigenetic modifications.
Their longer reads map repetitive genomic regions more accurately than short-read sequencing.
Studies show LRS identifies more unique structural variants and resolves intronic insertions and abnormal RNA splicing.
Fiber-Seq enables profiling of chromatin accessibility and epigenetic marks, informing genetic predispositions to disease.